Top Story

More than half of antiplatelet therapies prescribed inappropriately

July 25, 2017

Antiplatelet therapy is often improperly dispensed to acutely hospitalized elderly patients, according to research recently published in the British Journal of Pharmacology.

“There is little evidence favoring [antiplatelet] use in the frame of primary prevention, because several studies have shown less benefits than risks,” Ilaria Ardoino, PhD, of the department of clinical sciences and community health at the University of Milan, and colleagues wrote. “Thus, a careful risk/benefit appraisal is warranted for the optimal prescription of antiplatelet drugs in older people.”

Axsome launches phase 2/3 trial of AXS-05 for agitation in Alzheimer’s

July 21, 2017
Axsome Theraputics recently announced the initiation of a phase 2/3 trial assessing efficacy and safety of AXS-05, a combination of dextromethorphan and bupropion, for…
In the Journals

Childhood asthma tied to increased LV mass index in adulthood

July 21, 2017
Adults with a history of childhood asthma had an elevated left ventricular mass index, especially in those with prehypertension or hypertension, according to a study…
In the Journals

Another study finds no link between PPIs, dementia

July 20, 2017
Researchers report they found “no convincing evidence” of an association between the use of proton pump inhibitors and risk for dementia in a new study…
More Headlines »